View Results of the Latest ChangeWave Research Trends in Generic Drugs and Diabetes Treatments (July 2006)
Posted on: Wednesday, 20 December 2006, 12:01 CST
Research and Markets (http://www.researchandmarkets.com/reports/c47400) has announced the addition of Trends in Generic Drugs and Diabetes Treatments to their offering.
This report presents the findings of a recent Changewave Research survey on market trends in two medical areas: Generic Drugs and Diabetes Treatments. The survey was conducted June 27-30, 2006. A total of 244 healthcare members participated, including 148 doctors.
Questions Answered in this report:
Are healthcare professionals more willing to prescribe generic drugs today than they were a year ago?
Are consumers feeling pressured by HMO's and Health Insurance Providers to use generic drugs?
What categories of branded drugs are in the process of being displaced by generics?
For which drugs are physicians most likely to prescribe a generic?
How likely are physicians to prescribe a generic version of injectible insulin?
What percentage of patients will use a generic form of insulin if it becomes available?
What percentage of diabetes patients would prefer to use an inhalable form of insulin rather than the traditional injectable form?
What is the outlook for exuebra?
Why you should purchase this report?
Discover if the future looks bright for the generic drug industry
Find out the top drug categories being replaced by generics
Learn if Doctors are likely to prescribe generics for Zocor, Zoloft & Proscar
Understand how Doctors feel about inhalable insulin and whether they will be willing to prescribe it
Content Outline:
Overview
Summary of Key Findings
The Findings
Generic Drugs
Willingness to Prescribe Generic Drugs
Most Popular Generic Drugs
Zocor
Lipitor
Zolof
Proscar
Diabetes Treatments
Generic Injectable Insulin
Inhalable Insulin vs. Injectable Insulin
Exubera
ChangeWave Research Methodology
About ChangeWave Research
For more information visit http://www.researchandmarkets.com/reports/c47400
Source: Business Wire
Related Articles
- Scientists Mine Drugs Database For New Diabetes Treatment
- Spectrum Sells Injectable Generic Drugs to Sagent
- Spectrum Pharmaceuticals Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc.
- AmeriHealth New Jersey Promotes Generic Drug Usage Through Free One-Month Generic Samples
- NHS Could Save Millions By Prescribing Generic Drugs, NAO Reports
- Research Needed to Develop Generic Drugs
- FDA Authorizes GSK, Biovail Generic Drug
- Wal-Mart to Cut Prices for Generic Drugs
- Generic Drugs Take a Huge Slice of Market Share Pie
 |
 |
User Comments (0)
RSS Feeds